| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.4 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |